Pericardial effusion is prevalent among hospitalized patients with COVID-19, but is rarely due to pericarditis, according to a study published online March 21 in the Journal of the American Heart Association, ahead of presentation ...
Mar 25, 2022
0
7
Scientists at the University of Illinois at Urbana-Champaign and Mie University in Japan have developed monoclonal antibodies that prevent lung cell death in mouse models for idiopathic pulmonary fibrosis (IPF) and acute ...
Mar 23, 2022
0
77
People with psoriasis and psoriatic arthritis, collectively known as psoriatic disease, are more likely to develop cardiovascular disease than others in the general population. In a new study published in Arthritis & Rheumatology ...
Mar 9, 2022
0
5
Scientists at Oregon State University have made a key advance against dangerous and costly surgical site infections, the type of infection most commonly associated with health care procedures.
Feb 25, 2022
0
30
Adelaide researchers have discovered a new method to treat the rare and crippling blood cancer, myelofibrosis, that could have the potential to greatly extend lifespan while also significantly improving quality of life.
Feb 22, 2022
0
501
A moderate amount of a peptide-enhanced, biological cancer drug goes a long way in treating breast cancers that metastasize to the bone.
Jan 24, 2022
0
76
Despite unprecedented efforts to develop COVID-19 vaccines in record time amid the global pandemic, SARS-CoV-2 continues to spread rapidly with the emergence of new variants, such as Delta and Omicron, making the development ...
Jan 13, 2022
0
78
A research team at the Medical University of South Carolina (MUSC) led by Carol Feghali-Bostwick, Ph.D., reports in the Journal of Clinical Investigation (JCI) Insight that the E4 peptide reverses fibrosis, or scarring, in ...
Jan 10, 2022
0
57
Dyslipidemia is a major risk factor for cardiovascular disease, which can significantly shorten life expectancy. Recently, Prof. Yuichi Oike and his team of scientists at Kumamoto University, Japan, have successfully developed ...
Dec 14, 2021
0
0
A new way to treat cancer that has fewer side effects than conventional drugs could result from a targeted method for killing tumor cells in mice that was developed by a RIKEN-led team. The novel therapeutic triggers the ...
Dec 13, 2021
0
58
